Accordingly, IL-13-LCL-SIM treatment on M2 macrophages prior to being co-cultured with melanoma cells slightly decreased their pro-proliferative functions, more efficiently than LCL-SIM (Figure 2A). This evidence concerns the gene IL13 and melanoma.